TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/2/22 19:59 | 3/1/22 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McGrath Yvonne | MA | O | Chief Sc | S.d | -368 | 36.76 | 0 | -10 | -100 | 0 | D | ||||||||||||||
6/10/21 17:35 | 6/8/21 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McGrath Yvonne | MA | O | VP,Resea | S.d | -159 | 20.00 | 0 | -8 | -100 | 0 | D | ||||||||||||||
6/3/21 16:19 | 5/24/21 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McGrath Yvonne | MA | O | VP,Resea | S.ad | -174 | 21.92 | 0 | -8 | -100 | 0 | D | ||||||||||||||
6/3/21 16:17 | 6/1/21 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McGrath Yvonne | MA | O | VP,Resea | S.dm | -160 | 20.17 | 0 | -8 | -100 | 0 | D | ||||||||||||||
5/26/21 16:09 | 5/24/21 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McGrath Yvonne | MA | O | VP,Resea | S.d | -174 | 21.92 | 0 | -8 | -100 | 0 | D | ||||||||||||||
5/19/21 16:14 | 5/17/21 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McGrath Yvonne | MA | O | VP,Resea | S.d | -196 | 24.69 | 0 | -8 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |